ticker
Login
business news
Politics And Regulation
Markets
The Economy
Editor's Pick
trading and investing
Stocks
ETFs
Fixed Income
Earnings
Currencies
Commodities
Options
Taxes
Personal Finance
How To Trade
How To Invest
sectors
Biotech/pharma
Consumer
Energy
Financial
Global Markets
Media
Precious Metals
Real Estate
Technology
Transportation
special features
Wall Of Worry
Random Thoughts
Sports Business
Minyanville Press
Video
Hoofy & Boo
Radio
MV PREMIUM
subscriptions
Launch Buzz And Banter
Buzz And Banter
Elliott Wave Insider
Tchir's Fixed Income Report
Cooper's Market Report
Techstrat Report
Optionsmith
The Stock Playbook
Ad Free Minyanville
Minyanville Book Store
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
KALOBIOS PHARM
(NQ:
KBIO
)
5.820
USD
-0.250 (-4.12%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
6.080
Bid (Size)
5.810 (900)
Ask (Size)
5.870 (2800)
Prev. Close
6.070
Today's Range
5.750 - 6.090
52wk Range
5.500 - 8.250
Shares Outstanding
24,177,506
Dividend Yield
N/A
Top News
More News
KaloBios Reports First Quarter 2013 Financial Results
May 14, 2013
from
PR Newswire
KaloBios to Present at Credit Suisse Antibody Conference
May 08, 2013
from
PR Newswire
More News
Read More
Sofinnova Ventures Announces Team Expansion and Promotion
May 02, 2013
from
PR Newswire
KaloBios to Present at Needham Healthcare Conference
April 24, 2013
from
PR Newswire
Sanofi, KaloBios Pharmaceuticals (KBIO) Granted FDA Fast Track Status for KB001A
April 23, 2013
from
StreetInsider.com News Articles
U.S. FDA Grants Fast-Track Designation to Sanofi Pasteur and KaloBios' Novel Biologic Candidate for Pseudomonas aeruginosa
April 23, 2013
from
PR Newswire
KaloBios' Targeted Antibacterial KB001-A to be Featured in BIO 2013 Panel Discussion of "New Defenses Against Old Enemies"
April 17, 2013
from
PR Newswire
Top Performing Industries For April 15, 2013
April 15, 2013
category
KBIO
,
Benzinga
,
Movers
, and 7 more.
from
Latest Articles from Benzinga.com
KaloBios to Present at Future Leaders in the Biotech Industry Conference
April 01, 2013
from
PR Newswire
KaloBios Announces Fiscal Year 2012 Financial Results
March 27, 2013
from
PR Newswire
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Stay Connected
WHAT'S POPULAR IN THE VILLE
1
The Top 5 Spookiest Technologies
Nick Shchetko
2
1929, 1987, and 2013: Three of a Kind?
Jeffrey Cooper
3
The Tesla Model S Is the New Toyota Prius
Michael Comeau
4
Black Swan Watch: Mexico's Super Volcano Could Be the Next Market Catalyst
Duncan Parker
5
BlackBerry: Why Expanding BBM to iOS and Android Is Smart -- and Hazardous
Sterling Wong
See All Articles
»
Financial Product Guide